HMN 2025: How metabolic chatter between cells undermines anti-tumor immunity

A Ludwig Cancer Research study has recognized a posh chain of molecular chatter by which cancer cells, exploiting bizarre metabolic processes, program one set of noncancerous cells to govern one other set of such cells to assist their development and survival.

Researchers led by Ping-Chih Ho, Xiaoyun Li and Sofie Hedlund Møller of the Lausanne Branch of the Ludwig Institute for Cancer Research have found that sure fats molecules secreted by cancer cells immediate fibroblasts—workhorse cells usually coopted by tumors—to ramp up manufacturing of the amino acid glutamine.

They report within the Journal of Experimental Medicine that this amino acid switches immune cells often called macrophages right into a useful state through which they promote cancer cell proliferation and suppress anti-tumor immune responses.

“Our findings supply new insights into the complexity of the tumor microenvironment and illustrate a beforehand unknown mechanism by which cancer cells sculpt their metabolic surroundings to serve a number of wants,” mentioned Ho. “They additionally recommend potential methods to reprogram that microenvironment to assist anti-tumor immune responses and enhance the efficacy of immunotherapy.”

Researchers have a rising appreciation for the delicate roles seemingly humdrum cells like fibroblasts—which, amongst different issues, crank out the fibrous stuff of tissues—play in tumor biology. Recruited and reprogrammed by cancer cells, cancer-associated fibroblasts (CAFs) have been proven to secrete a number of immune elements that may alter the perform of immune cells like tumor-associated macrophages (TAMs) to allow tumor development and survival. CAFs additionally assist cancer cell metabolism, offering vitamins important to producing the power and mobile constructing blocks that maintain their fast proliferation.

In exploring how the metabolic profile of tumors shapes their immune landscapes, the Ludwig Lausanne researchers discovered glutamine to be notably plentiful in melanoma tumors. This was of quick curiosity to them as a result of the amino acid is thought to modulate the perform of TAMs. Further study revealed that glutamine synthetase (GS), an enzyme important to its biosynthesis, is expressed at particularly excessive ranges by CAFs in these tumors.

Møller, Li, Ho and colleagues found that palmitic acid (identical because the fats in palm oil) produced by melanoma cells engages receptors on the floor of CAFs that set off their expression of genes concerned in irritation. One of these genes is for interleukin-6 (IL-6), an element that acts on the infected CAFs themselves to ramp up their expression of GS. This in flip elevates glutamine ranges within the tumor microenvironment, pushing TAMs into an immunosuppressive and pro-tumorigenic state.

“Our findings reveal a brand new method that cancer hijacks surrounding cells to guard itself and develop,” mentioned Møller. “Glutamine metabolism is already being studied as a possible goal for cancer remedy attributable to its results on each cancer cells and immune cells. Our findings recommend that focusing on glutamine manufacturing in fibroblasts might contribute to the advantages of such therapies.”

The researchers describe of their paper the biochemical signaling cascades in CAFs that result in inflammatory responses, such because the manufacturing of IL-6 and GS. They additionally present that knocking out the gene for GS in fibroblasts reprograms TAMs and restores anti-tumor immunity, impairing tumor development in mouse models of melanoma.

Notably, the researchers additionally present that CAFs expressing genes required for glutamine synthesis are intently related to pro-tumorigenic TAMs in genomic datasets from breast cancer sufferers.

“Components of the signaling pathway that we discovered to be triggered by palmitic acid—akin to glutamine synthetase and proteins concerned within the inflammatory CAF responses—might be helpful as biomarkers,” mentioned Li. With additional study and affirmation of our findings, such markers may assist clinicians determine tumors which have an immunosuppressive microenvironment and are possible to withstand immunotherapy.”